The efficacy and safety of using botulinum toxin type A in treating spasticity resulting from stroke or traumatic brain injury: A systematic review with meta-analysis

董燕,吴涛,王彤
DOI: https://doi.org/10.3760/cma.j.issn.0254-1424.2020.12.015
2020-01-01
Abstract:Objective:To evaluate the efficacy and safety of using botulinum toxin type A (BoNT-A) in treating lower limb spasticity resulting from a stroke or traumatic brain injury (TMI).Methods:Reports of randomized and controlled trials of the effectiveness of BoNT-A treatment for lower limb spasticity resulting from stroke or TMI published before January 2019 were collected from the PubMed, EBSCO host, OVID Medline and Web of Science databases.Results:Seven studies with 1334 participants were found. Meta-analysis showed that a significant decrease in muscle tone was observed at the 4th, 8th and 12th weeks after BoNT-A injection compared to placebo injection. At the 4th week after the injection, active ankle dorsiflexion was also significantly improved. No significant differences were observed in the rate of adverse events, the average Fugl-Meyer scores, walking pace or walking distance between the two groups.Conclusion:BoNT-A injections can safely and effectively improve lower limb spasticity after stroke or traumatic brain injury.
What problem does this paper attempt to address?